Taken together, our observations suggest that upregulation of p-ERBB3, total ERBB3 and total DARPP-32 protein levels positively correlate with an EGFR TKI resistance phenotype in EGFR-mutated NSCLC cells. The gene discussed is ERBB3; the disease is non-small cell lung carcinoma.